Nasdaq
BIIB
Biogen Inc.
- Health Care
- 1 day
- −0.2%
- 1 month
- +0.3%
- 1 year
- +59.5%
$206.28 · Mkt cap $30.5B · P/E 23.47
At the 6 Aug 2026 close
Nasdaq
Biogen Inc.
$206.28 · Mkt cap $30.5B · P/E 23.47
At the 6 Aug 2026 close
Biogen Inc. trades under the ticker BIIB on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). Its market capitalisation is $30.5B. The last closing price was $206.28, on 6 Aug 2026. It trades at 23.47 times its last reported annual diluted earnings per share. Over the past year the share price is +59.5%, and +0.3% over the past month. Returns are price returns and exclude dividends.
This page exists because BIIB is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.